Oramed Pharmaceuticals Inc. Company Profile
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.
News Articles
JERUSALEM, November 7, 2012 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed using...
Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
JERUSALEM , February 18, 2013 /- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( http://www.oramed.com ), a developer of oral delivery systems, announced today that Dr. Ehud Arbit , Oramed's Dir...
Oramed, Medpace to collaborate on phase II trial
Oramed, a subsidiary of Jerusalem-based Oramed Pharmaceuticals, a developer of oral drug delivery systems, has retained Medpace as CRO for Oramed's upcoming phase II clinical trial on its oral insulin...
Oramed Pharma, Medpace collaborate on phase II FDA trial of oral insulin
Oramed Ltd., a subsidiary of Oramed Pharmaceuticals, a developer of oral drug delivery systems, has signed an agreement to retain Medpace as a full-service CRO for Oramed's upcoming phase II clinical...
Oramed Readies Oral Insulin Study In U.S.
By Len Zehr:Oramed Pharmaceuticals (NASDAQ:ORMP) is awaiting a decision from the FDA, possibly later this week, to conduct a sub-study of the safety of its oral insulin candidate, ORMD-0801, before pr...
Bioassociate Initiated Coverage On Oramed Pharmaceuticals With A Buy
By Tiran Rothman:Oramed Pharmaceuticals Inc. (ORMP) is a public biotechnology company based in Jerusalem, Israel. Oramed develops an orally ingestible capsule for the delivery of protein-based therapi...
Israel's Oramed to list shares on Nasdaq
JERUSALEM, Feb 7 (Reuters) - Oramed, an Israeli developer of oral drug delivery systems, said it will list its shares on the Nasdaq Capital Market starting on Monday in a bid to boost its investor bas...
Oramed applies for oral insulin trial in U.S.
JERUSALEM, April 11 (Reuters) - Oramed said it had applied to the U.S. Food and Drug Administration for approval to conduct a trial of an insulin capsule to treat Type II diabetes, which could slash t...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of...
Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of...
More Information about "Oramed Pharmaceuticals Inc." on BioPortfolio
We have published hundreds of Oramed Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Oramed Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Oramed Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oramed Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Oramed Pharmaceuticals Inc. Drugs and Medications on this site too.
